» Articles » PMID: 28100453

Mechanisms of Vasovagal Syncope in the Young: Reduced Systemic Vascular Resistance Versus Reduced Cardiac Output

Overview
Date 2017 Jan 20
PMID 28100453
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Syncope is a sudden transient loss of consciousness and postural tone caused by cerebral hypoperfusion. The most common form is vasovagal syncope (VVS). Presyncopal progressive early hypotension in older VVS patients is caused by reduced cardiac output (CO); younger patients have reduced systemic vascular resistance (SVR). Using a priori criteria for reduced CO (↓CO) and SVR (↓SVR), we studied 48 recurrent young fainters comparing subgroups of VVS with VVS-↓CO, VVS-↓SVR, and both VVS-↓CO&↓SVR.

Methods And Results: Subjects were studied supine and during 70-degrere upright tilt with a Finometer to continuously measure blood pressure, CO, and SVR and impedance plethysmography to estimate thoracic, splanchnic, pelvic, and calf blood volumes, blood flows, and vascular resistances and electrocardiogram to measure heart rate and rhythm. Central blood volume was decreased in all VVS compared to control. VVS-↓CO was associated with decreased splanchnic blood flow and increased splanchnic blood pooling compared to control. Seventy-five percent of VVS patients had reduced SVR, including 23% who also had reduced CO. Many VVS-↓SVR increased CO during tilt, with no difference in splanchnic pooling, caused by significant increases in splanchnic blood flow and reduced splanchnic resistance. VVS-↓CO&↓SVR patients had splanchnic pooling comparable to VVS-↓CO patients, but SVR comparable to VVS-↓SVR. Splanchnic vasodilation was reduced, compared to VVS-↓SVR, and venomotor properties were similar to control. Combined splanchnic pooling and reduced SVR produced the earliest faints among the VVS groups.

Conclusions: Both ↓CO and ↓SVR occur in young VVS patients. ↓SVR is predominant in VVS and is caused by impaired splanchnic vasoconstriction.

Citing Articles

Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection.

Zafeiropoulos S, Beccarino N, Stavrakis S, Zanos S, Mitra R JACC Case Rep. 2024; 29(13):102373.

PMID: 38827268 PMC: 11137558. DOI: 10.1016/j.jaccas.2024.102373.


Variability of cardioinhibition in vasovagal syncope: differences between subgroups during cardioinhibition and beyond.

van Rossum I, de Lange F, Benditt D, van Zwet E, van Houwelingen M, Thijs R Clin Auton Res. 2023; 33(6):749-755.

PMID: 37874434 PMC: 10751252. DOI: 10.1007/s10286-023-00991-5.


Clinical and Autonomic Profile, and Modified Calgary Score for Children and Adolescents with Presumed Vasovagal Syncope Submitted to the Tilt Test.

Oliveira P, da Silva R, Tonelli H, Meira Z, Mota C Arq Bras Cardiol. 2023; 120(7):e20220543.

PMID: 37556654 PMC: 10382152. DOI: 10.36660/abc.20220543.


Decreased cardiac output: an integrative review.

da Silva R, Gondim M, Melo G, da Silva V, Cavalcante A, Almeida M Rev Bras Enferm. 2023; 76(2):e20220265.

PMID: 36753257 PMC: 9901357. DOI: 10.1590/0034-7167-2022-0265.


[A 10-year retrospective analysis of spectrums and treatment options of orthostatic intolerance and sitting intolerance in children].

Cui Y, Du J, Zhang Q, Liao Y, Liu P, Wang Y Beijing Da Xue Xue Bao Yi Xue Ban. 2022; 54(5):954-960.

PMID: 36241239 PMC: 9568388.


References
1.
GREENWAY C, Lautt W . Distensibility of hepatic venous resistance sites and consequences on portal pressure. Am J Physiol. 1988; 254(3 Pt 2):H452-8. DOI: 10.1152/ajpheart.1988.254.3.H452. View

2.
HOLMAN E . CLINICAL AND EXPERIMENTAL OBSERVATIONS ON ARTERIOVENOUS FISTULAE. Ann Surg. 1940; 112(5):840-78. PMC: 1387980. DOI: 10.1097/00000658-194011000-00002. View

3.
Bearn A, BILLING B, Sherlock S . The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol. 1951; 115(4):430-41. PMC: 1392027. DOI: 10.1113/jphysiol.1951.sp004679. View

4.
Schadt J, Ludbrook J . Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol. 1991; 260(2 Pt 2):H305-18. DOI: 10.1152/ajpheart.1991.260.2.H305. View

5.
Taneja I, Medow M, Glover J, Raghunath N, Stewart J . Increased vasoconstriction predisposes to hyperpnea and postural faint. Am J Physiol Heart Circ Physiol. 2008; 295(1):H372-81. PMC: 2494751. DOI: 10.1152/ajpheart.00101.2008. View